(Q46047927)
English
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients
scientific article published on 16 April 2009
Statements
1 reference
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients (English)
1 reference
H P Mattle
1 reference
M G Bousser
1 reference
P Amarenco
1 reference
A Chamorro
1 reference
M Fisher
1 reference
I Ford
1 reference
K Fox
1 reference
M G Hennerici
1 reference
P M Rothwell
1 reference
PERFORM Study Investigators
1 reference
16 April 2009
1 reference
27
1 reference
5
1 reference
509-518
1 reference
Identifiers
1 reference
1 reference